May I suggest those interested go to 11.50 of the AGM presentation, it is fairly clear to me that the 3rd party investor will provide significant funding for the development of the immunotherapies business.
I couldn't translate that, (as hard as I tried and as much as I would like) to the investor buying out any of Admedus Limited's position in that separate immunotherapies business, sorry.
Upcoming Immunotherapies Deal (???), page-11
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |